Profile	GDS3514 / 209629_s_at
Title	Liposarcoma response to doxorubicin in vitro
Organism	Homo sapiens

Graph caption help

Sample	Title	Value	Rank
GSM325240	Patient no. 1: control	1769.83	82
GSM325241	Patient no. 1: treated	1738.69	83
GSM325242	Patient no. 9: control	939.706	74
GSM325243	Patient no. 9: treated	742.18	69
GSM325244	Patient no. 18: control	2243.27	87
GSM325245	Patient no. 18: treated	1839.93	84
GSM325246	Patient no. 12: control	1728.66	83
GSM325247	Patient no. 12: treated	1917.96	85
GSM325248	Patient no. 3: control	1742.62	82
GSM325249	Patient no. 3: treated	1931.95	84
GSM325250	Patient no. 7: control	7161.95	95
GSM325251	Patient no. 7: treated	8728.71	96
GSM325252	Patient no. 15: control	626.419	63
GSM325253	Patient no. 15: treated	1410.64	80
GSM325254	Patient no. 4: control	879.339	71
GSM325255	Patient no. 4: treated	1322.1	78
GSM325256	Patient no. 19: control	2811.08	89
GSM325257	Patient no. 19: treated	4097.56	92
GSM325258	Patient no. 14: control	8868.04	97
GSM325259	Patient no. 14: treated	7099.51	96
GSM325260	Patient no. 13: control	6161.1	95
GSM325261	Patient no. 13: treated	6134.93	95
GSM325262	Patient no. 17: control	1131.5	75
GSM325263	Patient no. 17: treated	673.183	65
GSM325264	Patient no. 10: control	1074.78	75
GSM325265	Patient no. 10: treated	1961.73	84
GSM325266	Patient no. 5: control	1068.96	74
GSM325267	Patient no. 5: treated	3895.51	91
GSM325268	Patient no. 11: control	692.264	64
GSM325269	Patient no. 11: treated	3170.54	90
GSM325270	Patient no. 6: control	1434.1	80
GSM325271	Patient no. 6: treated	2943.52	90
GSM325272	Patient no. 8: control	1890.66	85
GSM325273	Patient no. 8: treated	1798.52	84
GSM325274	Patient no. 16: control	391.18	53
GSM325275	Patient no. 16: treated	2192.77	86
GSM325276	Patient no. 2: control	5303.22	95
GSM325277	Patient no. 2: treated	7577.68	96